Literature DB >> 28643735

Modeling of lung cancer risk due to radon exhalation of granite stone in dwelling houses.

Akbar Abbasi1.   

Abstract

AIMS: Due to increasing occurrences of lung cancer, radon exhalation rates, radon concentrations, and lung cancer risks in several types of commonly used granite stone, samples used for flooring in buildings, have been investigated. SUBJECTS AND METHODS: We measured the radon exhalation rates due to granite stones by means of an AlphaGUARD Model PQ2000 in a cube container with changeable floor by various granite stones. The lung cancer risk and percentage of lung cancer deaths (LCRn) due to those conditions were calculated using Darby's model.
RESULTS: The radon exhalation rates ranged from 1.59 ± 0.41 to 9.43 ± 0.74 Bq/m 2/h. The radon concentrations in the standard room with poor and normal ventilation were calculated 20.10-71.09 Bq/m 3 and 16.12-47.01 Bq/m 3, respectively.
CONCLUSIONS: The estimated numbers of lung cancer deaths attributable to indoor radon due to granite stones in 2013 were 145 (3.33%) and 103 (2.37%) for poor and normal ventilation systems, respectively. According to our estimations, the values of 3.33% and 2.37% of lung cancer deaths in 2013 are attributed to radon exhalation of granite stones with poor and normal ventilation systems, respectively.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28643735     DOI: 10.4103/0973-1482.204851

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  2 in total

1.  Effect of human body position on gamma radiation dose rate from granite stones.

Authors:  Motahareh Kefalati; S Farhad Masoudi; Akbar Abbasi
Journal:  J Environ Health Sci Eng       Date:  2021-04-26

2.  Influences of COVID-19 pandemic lockdown on excess lifetime cancer risk value of natural radiation.

Authors:  Akbar Abbasi; Fatemeh Mirekhtiary; A El-Denglawey; Hesham M H Zakaly
Journal:  J Radioanal Nucl Chem       Date:  2021-07-27       Impact factor: 1.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.